AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Transaction in Own Shares Mar 4, 2011

3377_dirs_2011-03-04_2885e98e-5583-4559-b2d7-1129b960765b.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

March 4, 2011

On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.

Under the program Novozymes will buy back B shares for an amount of up to DKK 400 million in the period from February 11, 2011, to December 31, 2011.

The following transactions have been made under the program:

Number of
shares
Average purchase
price
Transaction value,
DKK
Accumulated, 28,180 24,411,056
last announcement
February 25, 2011 1,000 755.18 755,180
February 28, 2011 7,950 758.00 6,026,100
March 01, 2011 900 762.48 686,232
March 02, 2011 2,282 759.42 1,732,996
March 03, 2011 0 0 0
Accumulated under the 40,312 30,611,564
program

Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 8,018 B shares in the period from February 25 to March 3. The shares related to these transactions were not part of the Safe Harbour share buyback program.

With the transactions stated above, Novozymes owns a total of 1,935,743 treasury shares, corresponding to 3.0% of the share capital. The total amount of shares in the company is 65,000,000, including treasury shares.

Press and media: Investor Relations:
René Tronborg (Europe) Tobias Bjorklund
Tel. (direct): +45 4446 2274 Tel. (direct): +45 4446 8682
Tel. (mobile): +45 3077 2274 Tel. (mobile): +45 3077 8682
Paige Donnelly (USA) Martin Riise Nielsen
Tel. (direct): +1 919 494 3209 Tel. (direct): +45 4446 0738
Tel. (mobile): +1 919 218 4501 Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3483
Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Company announcement no. 13, 2011 Page 1 of 1
Novozymes A/S Krogshoejvej 36 Telephone: Internet:
Investor Relations 2880 Bagsvaerd +45 4446 0000 www.novozymes.com
Denmark Fax: CVR number:

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27

Talk to a Data Expert

Have a question? We'll get back to you promptly.